相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis
Azza AbuDagga et al.
BMC HEALTH SERVICES RESEARCH (2014)
Rates of hemorrhage during warfarin therapy for atrial fibrillation
Tara Gomes et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2013)
Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden
Thomas Davidson et al.
EUROPEAN HEART JOURNAL (2013)
Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation
Amanda R. Harrington et al.
STROKE (2013)
Early Adoption of Dabigatran and Its Dosing in US Patients With Atrial Fibrillation: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation
Benjamin A. Steinberg et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Adoption of new drugs by physicians: a survival analysis
Francisco Javier Garjon et al.
BMC HEALTH SERVICES RESEARCH (2012)
Oral Direct Factor Xa Inhibitors
Calvin H. Yeh et al.
CIRCULATION RESEARCH (2012)
Stitching the gaps in the Canadian public drug coverage patchwork? A review of provincial pharmacare policy changes from 2000 to 2010
Jamie R. Daw et al.
HEALTH POLICY (2012)
A systematic review of validated methods for identifying atrial fibrillation using administrative data
Paul N. Jensen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Dabigatran in atrial fibrillation: pharmacology and clinical trials
Michael D. Ezekowitz et al.
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY (2011)
Is new drug prescribing in primary care specialist induced?
Stefan R. Florentinus et al.
BMC HEALTH SERVICES RESEARCH (2009)
What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries
Marin C. Gemmill et al.
INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH (2008)
Warfarin prescribing in atrial fibrillation: The impact of physician, patient, and hospital characteristics
Niteesh K. Choudhry et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Economic evaluations in the Canadian common drug review
Andreas Laupacis
PHARMACOECONOMICS (2006)
Accuracy of coding for possible warfarin complications in hospital discharge abstracts
T. Arnason et al.
THROMBOSIS RESEARCH (2006)
Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations - How much is too much?
DW Roblin et al.
MEDICAL CARE (2005)
Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding
M Mamdani et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children
HA Huskamp et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Pharmacy benefits and the use of drugs by the chronically ill
DP Goldman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Whither seniors' pharmacare: Lessons from (and for) Canada
SG Morgan et al.
HEALTH AFFAIRS (2003)
Adjusting for multiple testing - when and how?
R Bender et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)
A dog's breakfast: Prescription drug coverage varies widely across Canada
AH Anis et al.
MEDICAL CARE (2001)
Socio-economic status and the utilisation of physicians' services: results from the Canadian National Population Health Survey
S Dunlop et al.
SOCIAL SCIENCE & MEDICINE (2000)